FR2111769B1 - - Google Patents

Info

Publication number
FR2111769B1
FR2111769B1 FR7137870A FR7137870A FR2111769B1 FR 2111769 B1 FR2111769 B1 FR 2111769B1 FR 7137870 A FR7137870 A FR 7137870A FR 7137870 A FR7137870 A FR 7137870A FR 2111769 B1 FR2111769 B1 FR 2111769B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7137870A
Other languages
French (fr)
Other versions
FR2111769A1 (sv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2111769A1 publication Critical patent/FR2111769A1/fr
Application granted granted Critical
Publication of FR2111769B1 publication Critical patent/FR2111769B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR7137870A 1970-10-22 1971-10-21 Expired FR2111769B1 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (sv) 1970-10-22 1970-10-22
GB963871 1971-04-16
GB4749171 1971-10-12

Publications (2)

Publication Number Publication Date
FR2111769A1 FR2111769A1 (sv) 1972-06-09
FR2111769B1 true FR2111769B1 (sv) 1974-10-18

Family

ID=27255400

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7137870A Expired FR2111769B1 (sv) 1970-10-22 1971-10-21

Country Status (20)

Country Link
JP (2) JPS5536662B1 (sv)
AR (3) AR192588A1 (sv)
AT (1) AT319948B (sv)
BE (1) BE774281A (sv)
BG (4) BG20365A3 (sv)
CA (1) CA967158A (sv)
CH (3) CH582681A5 (sv)
DD (1) DD100877A5 (sv)
DK (1) DK132174C (sv)
ES (1) ES396219A1 (sv)
FI (1) FI56175C (sv)
FR (1) FR2111769B1 (sv)
GB (1) GB1375162A (sv)
IE (1) IE37452B1 (sv)
IL (2) IL37984A (sv)
LU (1) LU64129A1 (sv)
MC (1) MC894A1 (sv)
NL (1) NL175178C (sv)
SE (2) SE384505B (sv)
ZM (1) ZM14971A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
MA18450A1 (fr) * 1978-05-24 1979-12-31 Wellcome Found Composition de benzylpirimidines
JPS61156909A (ja) * 1984-12-27 1986-07-16 Matsushita Electric Ind Co Ltd カレント・ミラ−回路
JPS62145907A (ja) * 1985-12-20 1987-06-30 Hitachi Ltd トランジスタ回路
RU2397171C2 (ru) 2004-03-26 2010-08-20 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. 9-замещенное производное 8-оксоаденина и лекарственное средство
EP2041135A4 (en) 2006-07-05 2010-12-01 Astrazeneca Ab As TLR7 MODULATORS, 8-OXOADENINE DERIVATIVES WORK
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
SI2132209T1 (sl) 2007-03-19 2014-05-30 Astrazeneca Ab Spojine 9-substituiranega-8-okso-adenina, kot modulatorji Toll-like receptorja (TLR7)
WO2008114006A1 (en) 2007-03-19 2008-09-25 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
JPWO2008114819A1 (ja) 2007-03-20 2010-07-08 大日本住友製薬株式会社 新規アデニン化合物
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
UY31531A1 (es) 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
CN102482233A (zh) 2009-05-21 2012-05-30 阿斯利康(瑞典)有限公司 新颖的嘧啶衍生物和它们在治疗癌症和其它疾病中的用途
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
JP5978225B2 (ja) 2010-12-16 2016-08-24 大日本住友製薬株式会社 治療に有用なイミダゾ[4,5−c]キノリン−1−イル誘導体
US8895570B2 (en) 2010-12-17 2014-11-25 Astrazeneca Ab Purine derivatives
CN104302628B (zh) 2012-05-18 2017-06-23 大日本住友制药株式会社 羧酸化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE710100A (sv) * 1967-02-02 1968-07-30
JPS511716A (ja) * 1974-06-25 1976-01-08 Toray Industries Horiesuterumaruchifuiramentono seiho

Also Published As

Publication number Publication date
AT319948B (de) 1975-01-10
BG21406A3 (sv) 1976-05-20
AR192588A1 (es) 1973-02-28
NL175178B (nl) 1984-05-01
NL7114494A (sv) 1972-04-25
SE409705B (sv) 1979-09-03
FI56175B (fi) 1979-08-31
AR192802A1 (es) 1973-03-14
JPS53135991A (en) 1978-11-28
CA967158A (en) 1975-05-06
FR2111769A1 (sv) 1972-06-09
DD100877A5 (sv) 1973-10-12
GB1375162A (sv) 1974-11-27
FI56175C (fi) 1979-12-10
IL37984A (en) 1976-03-31
BG20797A3 (sv) 1975-12-20
JPS5536662B1 (sv) 1980-09-22
BE774281A (fr) 1972-04-21
CH568301A5 (sv) 1975-10-31
SE384505B (sv) 1976-05-10
ES396219A1 (es) 1975-09-16
DK132174C (da) 1976-03-29
DK132174B (da) 1975-11-03
IL37984A0 (en) 1971-12-29
AR192803A1 (es) 1973-03-14
IE37452B1 (en) 1977-08-03
IE37452L (en) 1972-04-22
CH568302A5 (sv) 1975-10-31
IL45422A (en) 1976-03-31
LU64129A1 (sv) 1972-06-28
NL175178C (nl) 1984-10-01
BG20364A3 (sv) 1975-11-05
CH582681A5 (sv) 1976-12-15
ZM14971A1 (en) 1972-07-21
MC894A1 (fr) 1972-06-22
BG20365A3 (sv) 1975-11-05

Similar Documents

Publication Publication Date Title
AR204384A1 (sv)
FR2111769B1 (sv)
ATA96471A (sv)
AU1473870A (sv)
AU1146470A (sv)
AU1716970A (sv)
AU1833270A (sv)
AU1517670A (sv)
AU1336970A (sv)
AU1326870A (sv)
AR195465A1 (sv)
AU1581370A (sv)
AU1343870A (sv)
AU1943370A (sv)
AU1881070A (sv)
AU1879170A (sv)
AU1086670A (sv)
AU1872870A (sv)
AU1841070A (sv)
AU1083170A (sv)
AU1832970A (sv)
AU1189670A (sv)
AU1235770A (sv)
AU1247570A (sv)
AU1277070A (sv)

Legal Events

Date Code Title Description
ST Notification of lapse